TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Concord Medical Services ( (CCM) ) is now available.
Concord Medical Services announced its unaudited financial results for the first half of 2025, revealing a total net revenue of RMB200.6 million, an 8.3% decrease from the previous year. Despite a net loss of RMB27.1 million, the company showed significant improvement in its gross loss margin, which decreased from 19.0% to 2.1%, largely due to the commencement of proton therapy operations at Guangzhou Concord Cancer Hospital. This advancement has contributed to increased revenues in the hospital business, while the network business faced challenges due to decreased demand for medical equipment and software. The company remains committed to advancing proton therapy and enhancing operational efficiency, which is expected to improve patient outcomes and expand access to advanced diagnostic and therapeutic technologies.
The most recent analyst rating on (CCM) stock is a Hold with a $6.00 price target. To see the full list of analyst forecasts on Concord Medical Services stock, see the CCM Stock Forecast page.
Spark’s Take on CCM Stock
According to Spark, TipRanks’ AI Analyst, CCM is a Neutral.
The overall stock score is heavily influenced by Concord Medical Services’ poor financial performance, which is the most significant factor. While technical analysis shows some positive signs, the negative valuation metrics further weigh down the score.
To see Spark’s full report on CCM stock, click here.
More about Concord Medical Services
Concord Medical Services Holdings Limited is a healthcare provider in China, specializing in cancer treatment, research, education, and prevention. The company offers a full cycle of premium oncology services, including cancer diagnosis and treatment, with a focus on precision radiotherapy technologies such as proton therapy.
Average Trading Volume: 10,186
Technical Sentiment Signal: Sell
Current Market Cap: $27.09M
Learn more about CCM stock on TipRanks’ Stock Analysis page.